BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17349694)

  • 21. Immunogenicity of a new lot of Francisella tularensis live vaccine strain in human volunteers.
    Waag DM; Sandström G; England MJ; Williams JC
    FEMS Immunol Med Microbiol; 1996 Mar; 13(3):205-9. PubMed ID: 8861030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Susceptibility of various mouse strains to systemically- or aerosol-initiated tularemia by virulent type A Francisella tularensis before and after immunization with the attenuated live vaccine strain of the pathogen.
    Shen H; Chen W; Conlan JW
    Vaccine; 2004 Jun; 22(17-18):2116-21. PubMed ID: 15149767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ability of CpG oligonucleotides to protect mice against Francisella tularensis live vaccine strain but not fully virulent F. tularensis subspecies holarctica is reflected in cell-based assays.
    Rees DG; Hartley MG; Green M; Lukaszewski RA; Griffin KF; Atkins HS; Lyons R; Krieg AM; Titball RW
    Microb Pathog; 2013 Oct; 63():16-8. PubMed ID: 23707360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expansion and retention of pulmonary CD4
    Roberts LM; Wehrly TD; Crane DD; Bosio CM
    Vaccine; 2017 May; 35(19):2575-2581. PubMed ID: 28372827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcriptional profiling of recall responses to Francisella live vaccine strain.
    Paranavitana C; DaSilva L; Vladimirova A; Pittman PR; Velauthapillai M; Nikolich M
    Pathog Dis; 2014 Mar; 70(2):141-52. PubMed ID: 24453125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protection afforded against aerosol challenge by systemic immunisation with inactivated Francisella tularensis live vaccine strain (LVS).
    Eyles JE; Hartley MG; Laws TR; Oyston PC; Griffin KF; Titball RW
    Microb Pathog; 2008 Feb; 44(2):164-8. PubMed ID: 17904793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain.
    Pechous R; Celli J; Penoske R; Hayes SF; Frank DW; Zahrt TC
    Infect Immun; 2006 Aug; 74(8):4452-61. PubMed ID: 16861631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mice sublethally infected with Francisella novicida U112 develop only marginal protective immunity against systemic or aerosol challenge with virulent type A or B strains of F. tularensis.
    Shen H; Chen W; Conlan JW
    Microb Pathog; 2004 Aug; 37(2):107-10. PubMed ID: 15312850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful protection against tularemia in C57BL/6 mice is correlated with expansion of Francisella tularensis-specific effector T cells.
    Griffin AJ; Crane DD; Wehrly TD; Bosio CM
    Clin Vaccine Immunol; 2015 Jan; 22(1):119-28. PubMed ID: 25410207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dominance of human innate immune responses in primary Francisella tularensis live vaccine strain vaccination.
    Fuller CL; Brittingham KC; Hepburn MJ; Martin JW; Petitt PL; Pittman PR; Bavari S
    J Allergy Clin Immunol; 2006 May; 117(5):1186-8. PubMed ID: 16675351
    [No Abstract]   [Full Text] [Related]  

  • 31. Progress, challenges, and opportunities in Francisella vaccine development.
    Elkins KL; Kurtz SL; De Pascalis R
    Expert Rev Vaccines; 2016 Sep; 15(9):1183-96. PubMed ID: 27010448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Francisella tularensis Vaccines Elicit Concurrent Protective T- and B-Cell Immune Responses in BALB/cByJ Mice.
    De Pascalis R; Mittereder L; Chou AY; Kennett NJ; Elkins KL
    PLoS One; 2015; 10(5):e0126570. PubMed ID: 25973794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expansion of Vgamma9 Vdelta2 T cells is triggered by Francisella tularensis-derived phosphoantigens in tularemia but not after tularemia vaccination.
    Poquet Y; Kroca M; Halary F; Stenmark S; Peyrat MA; Bonneville M; Fournié JJ; Sjöstedt A
    Infect Immun; 1998 May; 66(5):2107-14. PubMed ID: 9573096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell-mediated and humoral immune responses after vaccination of human volunteers with the live vaccine strain of Francisella tularensis.
    Waag DM; McKee KT; Sandstrom G; Pratt LL; Bolt CR; England MJ; Nelson GO; Williams JC
    Clin Diagn Lab Immunol; 1995 Mar; 2(2):143-8. PubMed ID: 7697521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic engineering of Francisella tularensis LVS for use as a novel live vaccine platform against Pseudomonas aeruginosa infections.
    Robinson CM; Kobe BN; Schmitt DM; Phair B; Gilson T; Jung JY; Roberts L; Liao J; Camerlengo C; Chang B; Davis M; Figurski L; Sindeldecker D; Horzempa J
    Bioengineered; 2015; 6(2):82-8. PubMed ID: 25617059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccination evokes gender-dependent protection against tularemia infection in C57BL/6Tac mice.
    Sunagar R; Kumar S; Franz BJ; Gosselin EJ
    Vaccine; 2016 Jun; 34(29):3396-404. PubMed ID: 27182819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural killer and CD8 T cells dominate the response by human peripheral blood mononuclear cells to inactivated Francisella tularensis live vaccine strain.
    Gosselin EJ; Gosselin DR; Lotz SA
    Hum Immunol; 2005 Oct; 66(10):1039-49. PubMed ID: 16386645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BALB/c mice, but not C57BL/6 mice immunized with a ΔclpB mutant of Francisella tularensis subspecies tularensis are protected against respiratory challenge with wild-type bacteria: association of protection with post-vaccination and post-challenge immune responses.
    Twine S; Shen H; Harris G; Chen W; Sjostedt A; Ryden P; Conlan W
    Vaccine; 2012 May; 30(24):3634-45. PubMed ID: 22484348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A defined O-antigen polysaccharide mutant of Francisella tularensis live vaccine strain has attenuated virulence while retaining its protective capacity.
    Sebastian S; Dillon ST; Lynch JG; Blalock LT; Balon E; Lee KT; Comstock LE; Conlan JW; Rubin EJ; Tzianabos AO; Kasper DL
    Infect Immun; 2007 May; 75(5):2591-602. PubMed ID: 17296751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toll-like receptor 2-mediated signaling requirements for Francisella tularensis live vaccine strain infection of murine macrophages.
    Cole LE; Shirey KA; Barry E; Santiago A; Rallabhandi P; Elkins KL; Puche AC; Michalek SM; Vogel SN
    Infect Immun; 2007 Aug; 75(8):4127-37. PubMed ID: 17517865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.